We are delighted to share Thuja's 2023 Impact & ESG Annual Report!
Thuja invests exclusively in companies that offer solutions to high unmet medical needs, expected to have a major impact on human health through increasing healthy life expectancy, improving quailty of life and/or reducing health care costs. Here we report on the expected impact of our portfolio companies, based on our internally developed impact framework, along with our additionality as an early-stage hands-on investor (at the level of our portfolio companies and on the wider innovation ecosystem). In addition, we report on our approach to measuring and managing ESG-related risks and opportunities material to our portfolio, as we believe this is key to creating sustainable business and driving value.
2023 was the second year in which we implemented our impact and ESG approach for the Thuja Capital Healthcare Fund III portfolio. Whilst our approach to impact and ESG is continually evolving, we are delighted to see the strength and robustness of our approach as it is translated into action.
We are curious to learn what you think and would be keen to receive feedback.
You can read the full report here: 2023 Impact & ESG Annual report.